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Recent research suggests oral contraceptive use is associated with altered memory for emotional 
story information, blunted stress hormone responses to emotional stimuli, and altered structure or 
function of the amygdala and hippocampus. This study examined the extent to which oral 
contraceptives influence relative recall of: (a) the spatial location of emotional versus neutral 
stimuli, and (b) positive versus negative emotional stimuli. Participants (58 oral contraceptive 
users, 40 nonusers, and 37 men) completed an emotional spatial memory test and were evaluated 
on short-term recall and long-term (one week) recall. There was no evidence for group 
differences in recall of the locations of emotional versus neutral stimuli. However, oral 
contraceptive users remembered relatively more positive than negative items compared to 
nonusers and men on the spatial memory test.  This effect was driven by oral contraceptive users 
recalling fewer negative items than free-cyclers. The results indicate that hormonal 
contraceptives may decrease immediate recall of negative emotional stimuli.  
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Emotional Memory in Oral Contraceptive Users: Negative Stimuli are More Forgettable 
Introduction 
Research indicates that hormones can affect cognition and mood, and menstrual cycle phase has also been 
linked with cognition and mood (see reviews in Erlanger, Kutner, & Jacobs, 1999; Romans, Clarkson, Einstein, 
Petrovic, & Stewart, 2012; Steiner, Dunn, & Born, 2003).  Studies have suggested three other relevant findings.  (a) 
Emotional images elicit different levels of activity in the hippocampus and amygdala at low versus high hormone 
times in the menstrual cycle (Andreano & Cahill, 2010). (b) Oral contraceptives (OCs) can influence mood (see 
reviews in Kurshan & Epperson, 2006; Oinonen & Mazmanian, 2002). (c) OCs may influence amygdala and 
hippocampal structure and function (e.g., Lisofsky, Riediger, Gallinat, Lindenberger, & Kuhn, 2016).  Recent 
reviews of the effects of OCs on cognition (Gogos, Wu, Williams, & Byrne, 2014; Warren, Gurvich, Worsley, & 
Kulkarni, 2014) suggest that, while experimental designs have been weak, OCs may improve verbal memory, 
associative learning, and spatial attention. However, little is known about the effects of OCs on emotional memory. 
Given that approximately 82% of women between the ages of 15 and 44 in the United States take OCs during their 
lifetime (Mosher & Jones, 2010) and that emotional side effects are a common complaint (Rosenberg & Waugh, 
1998; Sanders, Graham, Bass, & Bancroft, 2001), there is a need to understand possible effects of OCs on emotional 
memory.  Research in this area also contributes to understanding of general hormonal mechanisms in memory, 
emotion, and emotional memory.    
Nielsen, Ertman, Lakhani, and Cahill (2011) found that OC use was associated with altered memory for an 
emotional story.  Women using OCs exhibited enhanced memory of gist (central information), but not story details, 
in an emotional story condition compared with a neutral story condition. Given that participants were exposed to 
only the emotional or the neutral story, the findings require replication using a within-subjects design whereby 
women’s memory for both emotional and neutral information is tested.  
Subsequent studies further suggest that OCs may affect memory for emotional information. One study 
examined the effects of OC use on long-term (one-week) recall of positive, negative, and neutral images as a 
function of a woman’s stress hormone responses (Nielsen, Segal, Worden, Yim, & Cahill, 2013). OC users showed 
blunted stress hormone responses compared to nonusers but no overall group difference in memory for any 
emotional stimuli. Weak interactions between OC use, stress hormone response (yes/no), and valence of the stimuli 
(positive or negative) on long-term (one-week) recall of the images suggest that OC users and nonusers may differ 




in their ability to recall positive or negative stimuli depending on their cortisol responses. Six other studies found 
that OCs may influence emotional learning or memory (i.e., Drexler, Merz, Hamacher-Dang, & Wolf, 2016; 
Graham & Milad, 2013; Merz et al., 2012; Nielsen, Ahmed, & Cahill, 2014; Petersen, Patihis, & Cahill, 2014; 
Zsido, 2014). However, only two studies appear to have looked at whether OCs affect spatial memory (Postma et al., 
1999; Lisofsky et al., 2016), and no published studies have examined the relationship between OC use and memory 
for the location of emotional stimuli, relative memory for the location of emotional versus neutral stimuli, or relative 
memory for positively- and negatively- valenced stimuli (but see Nielsen, Segal, et al., 2013 for a study using 
images). 
There is evidence that OCs may affect brain structure and activity that is of potential relevance to emotions 
and memory.  OC users show:  (a) decreased gray matter volume in the left amygdala/anterior parahippocampal 
gyrus in (Lisofsky et al., 2016), (b) decreased bilateral amygdala reactivity in response to negatively valenced 
emotional stimuli (Peterson & Cahill, 2015), (c) increased regional grey matter volumes in the prefrontal cortices, 
pre- and postcentral gyri, parahippocampal and fusiform gyri and temporal regions (Pletzer, Kronbichler, Nuerk, & 
Kerschbaum, 2014), and (d) localized decreases in cortical thickness in areas such as the lateral orbitofrontal cortex 
and posterior cingulate cortex (Peterson, Touroutoglou, Adreano, & Cahill, 2015). Another study found that OC 
users with a history of OC-related negative mood side effects show reduced left insula reactivity in BOLD responses 
to an emotion processing task when compared to placebo users after 21 days of OC use (Gingnell et al., 2013). 
Women with a history of OC-induced adverse mood side effects also showed the following changes when re-
exposed to OC use: lower reactivity to emotional faces in the left insula, left middle frontal gyrus, and bilateral 
inferior frontal gyri compared to similar women exposed to placebo.  Thus, recent research suggests neurobiological 
changes in OC users that could affect memory for emotional information.   
Estradiol may enhance memory due to its ability to facilitate dendritic spine growth and neuroplasticity in 
the CA1 of the hippocampus (see reviews in Frankfurt & Luine, 2015; Frick, 2015).  Repeated exposure to estradiol 
in female rodents modulates hippocampal neurogenesis and there is evidence of dose-dependent effects in brain 
areas that play a role in working memory (hippocampus, prefrontal cortex), spatial reference memory 
(hippocampus), and emotion (amygdala) (see review in Galea et al., 2008). OCs reduce endogenous levels of 
estradiol and testosterone (which is aromatized to estradiol) and reduce variability in estradiol across the cycle 
(Coenen et al., 1996; Fleischman et al., 2010; Gaspard et al., 1983; Kjeld, Puah, & Joplin, 1976). Thus, it is possible 




that OCs could adversely affect memory.  In addition, OCs reduce the cortisol response to stress (Kirschbaum & 
Hellhammer, 1995; Kirschbaum, Platte, Pirke, & Hellhammer, 1996; Kuhlmann & Wolf, 2005) and thus may also 
adversely affect memory in this way.  However, convincing evidence of an adverse OC-memory effect has not been 
found. 
Given evidence that OCs affect mood and may cause differential recall of emotional and neutral story 
information, it follows that there might also be adverse or differential effects of OCs on recall of emotional versus 
neutral spatial information, or on positively versus negatively valenced information. An adequately powered study 
without additional stressors or other factors that could influence mood (e.g., the possible influence of saliva 
sampling on mood) is needed to examine immediate and long-term recall of such emotional stimuli.  
The present study compared the performance of OC users, nonusers, and men on an Emotional Spatial 
Memory test created for the present study.  The relative recall of emotional versus neutral stimuli, and positive 
versus negative stimuli was examined and two hypotheses were tested.  (1) OCs influence relative memory for the 
spatial location of recalled emotional versus neutral stimuli. (2) OCs influence relative memory for positively- and 
negatively-valenced stimuli.  These hypotheses were nondirectional in nature as there was not enough consistent 
previous research to justify a directional hypothesis.  
	
Method 
Participants   
 The final sample consisted of 135 Canadian university students and community volunteers aged 16 to 35 
(58 women currently using OCs, 40 nonusers, and 37 men).  Their mean age was 20.16 (SD = 3.82), mean years of 
education was 13.88 (SD = 1.44), and 87.3% of the sample was of European decent.  Participants in eligible 
psychology courses received course credit for participation.  The University Research Ethics Committee approved 
the study.  
Initially, 282 participants completed the screening questionnaire and met the inclusion criteria for the study.  
Of these, 150 and 147 participants completed the first and second laboratory sessions, respectively. The four main 
inclusion criteria (and number of relevant participants excluded) were: (a) age 16 to 35 (n = 9), (b) no history of 
brain injury or a diagnosed memory problem (n = 13), (c) no use of mood-altering medications, other than OCs (e.g. 
antidepressants, benzodiazepines) (n = 37), and (d) geographic location (i.e., must be living in the city to attend lab 




sessions) (n = 50).  Five additional inclusion criteria were used for women: (e) no current pregnancy, lactation, or 
breast feeding (n = 5), (f) no hysterectomy or menopausal status (n = 5), (g) must have menstruated in the past two 
months (n = 9), (h) a regular menstrual cycle or provide enough menstrual cycle information to determine cycle day 
(n = 18), and (i) OC use for at least the past two months (for OC users) or no use of OCs for at least the past two 
months (nonusers) (n = 8).  Post-hoc exclusion criteria included: (a) not self-identifying as male or female (n = 1), 
(b) current high alcohol intake (i.e., five or more alcoholic drinks in the 24 hours prior to sessions) (n = 4), (c) a 
change in OC status between screening and laboratory sessions (n = 1), and (d) other hormonal contraceptive use 
(i.e., NuvaRing) (n = 7).  As in Nielsen et al. (2011), recruitment of OC users was targeted at monophasic users, 
with 76% of the OC users taking a monophasic OC.  
 
Measures and tests 
Screening questionnaire.  This questionnaire was used to evaluate the inclusion and exclusion criteria.  It included 
questions about demographics (e.g., age, sex, ethnicity), memory, OC use, menstrual cycle phase and other factors 
that could affect memory such as stress, sleep, alcohol and caffeine consumption, medications, and medical and 
psychological conditions.  
 
Emotional spatial memory test.  This test of visuospatial memory was designed for the present study to assess: (a) 
memory for the location of visuospatial material with differing emotional valence, and (b) memory for stimuli with 
positive, negative, and neutral emotional valence.  The test materials consist of a tray containing 30 items (10 
positive, 10 negative, and 10 neutral items), with one item found within each of the 30 sections of the tray.  The 
stimuli were selected through a pilot study (see Table 1 for emotional valence ratings of the stimuli).  In Laboratory 
Session I participants were instructed to carefully look at all items on the tray and “think about how each item makes 
you feel”.  This instruction was given to enhance the emotional value of the stimuli and to provide participants with 
a common activity that maximized the likelihood that the items were attended to.  After 60 seconds a towel was 
placed over the tray and the tray was removed from the participant’s view.  An immediate free recall test followed. 
Participants were asked to list as many items as they could remember (ST Item Recall).  To assess spatial memory, a 
second memory test was given where participants were presented with an identical empty tray and asked to indicate 
the location of each item they remembered (ST Spatial Memory).  In Laboratory Session II (one week later)  






Emotional Spatial Memory Test Stimuli: Emotional Valence Ratings in the Pilot Study and Main Study. 
 
Item                              Participants Indicating a Positive,        Mean (SD)        Mean (SD) 
    Negative, or Neutral Rating (%)   (Pilot Study)   (Main Study)  
    (Pilot Study) 
 
Skull    93.34% negative   1.47 (0.83)      2.15 (0.98) 
Spider    93.33% negative   1.47 (1.06)      1.98 (1.01) 
Bat    86.67% negative   1.80 (1.08)      2.38 (1.03) 
Rat    86.67% negative   1.67 (0.72)      2.27 (1.00) 
Payment Due Notice  86.67% negative   1.73 (0.70)      1.65 (0.91) 
Gun    80.00% negative   1.53 (0.83)      2.05 (1.03) 
Handcuffs   80.00% negative   1.73 (0.96)      2.34 (0.94) 
Pin/Needle   80.00% negative   1.93 (0.70)      2.46 (0.81) 
Tombstone   80.00% negative   1.53 (0.99)      1.83 (1.05) 
Knife    73.34% negative   1.67 (1.05)      1.95 (0.95)   
Button    80.00% neutral   3.13 (0.64)      3.16 (0.65) 
Paper Clip   80.00% neutral   3.07 (0.46)      3.13 (0.61) 
Pen Cap    80.00% neutral   2.80 (0.41)      2.93 (0.51) 
Rubber Elastic   80.00% neutral   2.93 (0.46)      3.06 (0.50) 
Twist Tie   80.00% neutral   2.93 (0.46)      2.99 (0.53) 
Bobby Pin   73.33% neutral   3.33 (0.62)      3.34 (0.64) 
Key    73.33% neutral   3.33 (0.62)      3.26 (0.64) 
Thread    73.33% neutral   3.07 (0.70)      3.22 (0.64) 
Toothpick   73.33% neutral   2.87 (0.52)      2.89 (0.57) 
Clothes Peg   60.00% neutral   3.00 (0.93)      3.03 (0.61)  
Heart    100% positive   4.80 (0.41)      4.02 (0.75)  
Present    100% positive   4.80 (0.41)      4.28 (0.64)  
Rainbow   100% positive    4.80 (0.41)      4.30 (0.65)   
Winking Face   100% positive   4.53 (0.52)      4.29 (0.77) 
Bow    93.34% positive   4.40 (0.63)      4.39 (0.65) 
Cake Slice   93.34% positive   4.40 (0.63)      4.20 (0.73)  
Happy Face   93.34% positive   4.60 (0.63)      4.33 (0.61) 
Peace Sign   93.34% positive   4.40 (0.63)      4.07 (0.77) 
Birthday Candle   93.33% positive   4.47 (0.64)      4.23 (0.73) 
Flower    93.33% positive   4.53 (0.64)      4.48 (0.63)  
 
Note: N = 15 for columns 2 and 3 (Pilot Study); N = 135 for column 4 (Main Study). Response options ranged from 











participants were asked to recall all items they saw on the tray during session I (LT Item Recall) and to indicate the 
location of each item on the tray (LT Spatial Memory). ST and LT spatial memory scores (i.e., the number of items 
that were correctly recalled and their exact location identified) and the total number of correctly recalled positive 
and negative items were calculated for both ST and LT recall. The spatial memory scores were further broken down 
by emotional or neutral valence of the stimuli. 
 
Attention Test.  The Choice Reaction Time for Single Digits test from the California Computerized Assessment 
Package (CalCap) (Miller, 1990) was used to assess for any group differences in complex attention during the study.  
Participants are to press a key as soon as they see a specific number on the screen, requiring a simple element of 
working memory, selective attention, and inhibition.  Internal consistency is quite high (r = .81 to .96) (Miller, 
1990).  The d prime scores or the discriminability index from the Choice Reaction Time test was used as an index of 
attention and the ability to accurately discriminate target stimuli from distracter stimuli.   
 
Positive and negative affect schedule (PANAS).  The PANAS consists of 20 adjectives that describe affective states 
(10 negative affect (NA) and 10 positive affect (PA) items; Watson, Clark, & Tellegen, 1988).  Participants 
indicated the extent to which they currently felt each affective adjective.  Response options ranged from 1 (very 
slightly or not at all) to 5 (extremely).  Coefficient alphas for the PA and the NA subscales are .89 and .87, 
respectively (Watson et al., 1988).  The PANAS was completed three times (start of laboratory session I (baseline 
measure), end of laboratory session I (after viewing the emotional stimuli), and during laboratory session II) to 
assess affect level and reactivity in response to the emotional stimuli.  
 
Procedure  
Recruitment and screening.  Participants in the “Hormones and Cognition” study provided informed consent, 
completed the Screening Questionnaire, and were selected for Laboratory Session I based on the above inclusion 
criteria.  For women, sessions were scheduled based on menstrual cycle phase using information provided in the 
screening and laboratory questionnaires.  Actual cycle days of testing were later confirmed using date of the next 
menstrual period (e.g., Hatta & Nagaya, 2009; Protopopescu et al., 2008).  Individual men were booked on the same 
days as individual women in order to yoke the men’s testing days with women’s and minimize testing day sex 




differences.  Women were tested in one of three phases (i.e., menstrual, periovulatory, or luteal) and the proportion 
of women in the three phases did not differ between the OC user and nonuser groups, X2 (2, N = 98) = 1.761, p = 
.415. Both sessions were scheduled in the laboratory between the hours of 12:00 and 18:00, as in previous studies 
(e.g., Nielsen et al., 2011).  
 
Laboratory questionnaires I and II.  These questionnaires were similar and contained questions about factors 
theoretically relevant to memory (e.g., sleep, alcohol and caffeine consumption, tobacco use, medications, fatigue, 
boredom, and interest).   
 
Laboratory session I.  Participants completed Laboratory Questionnaire I (including the PANAS), the Emotional 
Spatial Memory test (exposure and ST recall), the attention test, and the PANAS a second time.   
  
Laboratory session II.  One week later, participants returned for the last phase of the study. LT recall was tested for 
the Emotional Spatial Memory test, and then the Laboratory Questionnaire II and the PANAS were also completed.   
 
Data reduction and analyses. For the emotional spatial memory test, emotional : neutral spatial memory scores 
[number of emotional items recalled and located / number of neutral items recalled and located] and positive : 
negative item memory scores [number of positive items recalled / number of negative items recalled] were 
computed using both ST and LT memory scores.   
Two main sets of analyses were carried out using multivariate analysis of covariance (MANCOVA) to 
examine group differences in (a) emotional : neutral ST and LT spatial memory scores (Hypothesis 1), and (b) ST 
and LT positive: negative item recall scores from the Emotional Spatial Memory test (Hypothesis 2). Follow-up 
ANCOVAs were conducted where justified in order to examine group differences on the individual memory scores.  
For all analyses, a significance level of p < .05 was chosen.  Pillai’s trace criterion was used to evaluate multivariate 
significance and Bonferroni adjustment was used for follow-up pairwise comparisons.  All means reported are 
untransformed unadjusted means, unless otherwise indicated and figures represent adjusted means and their standard 
errors.    
 





Data Screening/ Statistical Considerations  
Assessing univariate assumptions.  All distributions were reasonably normally distributed.  As some outliers in each 
group (i.e. z scores > │3.29│; Tabachnik & Fidell, 2001) represented true data points, each analysis was run twice, 
both with and without outliers.  As findings were similar for all analyses, the analyses reported below include 
outliers.  As an additional control for possible violations of statistical assumptions, significant parametric analyses 
were followed up with nonparametric tests (i.e., Kruskal-Wallis analysis of ranks and Mann-Whitney U tests), which 
require that fewer normality assumptions be met.   
 
Examination of Group Equivalency  
The three groups were examined for equivalency on demographic, cognitive, and substance use variables using 
univariate ANOVAs and chi-square tests (see Tables 2 and 3).  Group differences were found for diagnosis of an 
attention problem (men more likely than OC users (p = .026) and nonusers (p = .046)); typical alcohol use (lower in 
nonusers than both OC users (p = .046) and men (p = .013)); and caffeine consumption in the 24 hours prior to the 
first laboratory session (higher in nonusers than OC users (p = .037)).  The three groups did not differ on attention 
scores, F(2, 132) = 0.547, p = .580.  Given general population sex differences in ADHD (American Psychiatric 
Association, 2013) and that there was no evidence of a difference in attention during the lab session, diagnosis of an 
attention problem was not used as a covariate in the main analyses.  However, given that both typical alcohol use 
(see review in Zeigler et al., 2005) and caffeine consumption prior to the first lab session (see review in Ruxton, 
2008) could affect memory, these two variables were used as covariates in the main analyses.     
 
Main Analyses 
 Means and standard deviations for the raw scores used in the main analyses are provided in Table 4 (see 
Table 4).  
 
Hypothesis 1. The overall multivariate examination of group differences in ST and LT emotional: neutral spatial 
memory scores was nonsignificant, F(4, 252) = 0.181, p = .948. The univariate ANCOVAs also did not reveal any  
 





Examination of Group Equivalency between Nonusers, Oral Contraceptive (OC) users, and Men: Means (and SDs).  
Variable       Nonusers            OC users          Men 
         n = 40              n = 58           n = 37 
                        Mean (SD)  
Age (years)    20.95 (5.42)        19.60 (2.70)            20.22 (3.24)  
Education (years)    13.43 (0.98)        13.97 (1.54)    14.27 (1.59) 
Typical drug use score   1.41 (0.90)        1.31 (0.66)    1.19 (0.46) 
Typical alcohol use score *  7.54 (5.99)x        11.74 (8.77)    13.11 (9.48)    
Sess. 2 Sleep (hours) a   8.20 (1.40)        8.14 (1.60)    8.42 (2.01)  
Sess. 2 Fatigue    1.65 (0.98)                  1.49 (0.80)    1.25 (0.77) 
Sess. 2 Interest    2.15 (0.77)        2.02 (0.77)    2.09 (0.70) 
Attention Score (CalCap)   0.99 (0.01)        0.99 (0.02)    1.00 (0.10)  
Note: a data refers to experience during the past 24 hours. x this group differed from the other two groups. The groups 
differed on typical alcohol use, F(2, 130) = 4.807, p = .010. 



















Examination of Group Equivalency between Nonusers, Oral Contraceptive (OC) users, and Men: Frequencies 
(Percentages).  
 
Variable       Nonusers            OC users            Men 
         n = 40              n = 58           n = 37 
 
 
Diagnosis of attention problem *  
Yes    0 (0.0%)               0 (0.0%)                 3 (8.1%) 
 No    40 (100.0%)        58 (100.0%)    34 (91.9%) 
Tobacco use 
Yes    2 (5.0%)                  1 (1.7%)                 1 (1.7%) 
 No    38 (95%)        57 (98.3%)   36 (97.3%) 
Sess. 1 alcohol use a  
 Yes    4 (10.3%)        3 (5.2%)                 4 (10.8%) 
 No    35 (89.7%)        55 (94.8%)             33 (89.2%) 
Sess. 1 caffeine use a * 
 Yes    16 (40.0%)       10 (17.2%)              10 (27.0%) 
 No    24 (60.0%)       48 (82.8%)              27 (73.0%) 
Sess. 1 Drug use a  
 Yes    2 (5.0%)                0 (0.0%)                0 (0.0%) 
 No    38 (95.5%)       58 (100.0%)  37 (100.0%) 
Sess. 2 alcohol use a  
 Yes    3 (7.5%)                4 (7.0%)              5 (14.7%) 
 No    37 (31.1%)       53 (93.0%)              29 (85.3%) 
Sess. 2 caffeine use a   
 Yes    15 (37.5%)       12 (21.1%)              9 (25.0%) 
 No    25 (62.5%)       45 (78.9%)              27 (75.0%) 
Sess. 2 Drug use a  
 Yes    2 (5.1%)               1 (1.8%)               0 (0.0%) 
 No    37 (94.9%)       56 (98.2%)             36 (100.0%) 
 
Note: a data refers to experience during the past 24 hours. The groups differed on diagnosis of an attention problem, 
X2 (2, N = 135) = 8.127, p = .017; typical alcohol use, F(2, 130) = 4.807, p = .010; and caffeine consumption in the 
24 hours prior to session 1, X2 (2, N = 135) = 6.274, p = .043.  













Table 4  
Unadjusted Means and Standard Deviations for Raw Scores and Ratio Scores on the Emotional Spatial Memory 
Test and the Positive and Negative Affect Schedule.  
 
   
Measures     Nonusers          OC users                   Men 
        n = 39             n = 57     n = 34 
 
Emotional Spatial Memory Test 
  Emotional : Neutral ST   3.25 (1.54)          3.52 (1.99)        3.46 (2.40)  
  Emotional : Neutral LT   2.70 (1.53)          2.74 (1.65)        3.03 (1.81) 
  Positive : Negative ST**   0.78 (0.24)         0.97 (0.44)x        0.76 (0.28)  
  Positive : Negative LT   0.83 (0.35)         0.92 (0.42)        0.80 (0.44)  
  Negative Item ST*   5.97 (1.61)y         5.17 (1.84)y        5.67 (1.35) 
  Positive Item ST   4.28 (1.72)         4.48 (1.43)        3.92 (1.57) 
 
Positive and Negative Affect Schedulea  
  Mean PAb     26.92 (7.15)         25.41 (6.02)      28.39 (6.33)  
  Mean NAb**     15.48 (5.96)x             13.40 (2.77)      12.56 (2.60) 
  PA Rangeb     7.04 (0.67)         5.91 (0.54)          6.61 (0.69)  
  NA Rangeb*    5.59 (5.48)y         4.29 (4.25)         2.97 (2.21)y 
  Lab 1 NA before   14.28 (5.73)         13.02 (2.79)      12.91 (3.23) 
  Lab 1 NA after*    15.75 (7.14)x          13.41 (4.12)      12.89 (3.30) 
  Lab 2 NA**    16.42 (7.58)y          13.76 (4.44)     11.89 (2.49)y 
 
Note: While data reported here are unadjusted for covariates, all analyses controlled for typical alcohol use and 
caffeine consumption. ST = Short-Term, LT = Long-Term.   
aNs ranged from 122 to 133 for MANCOVA and ANCOVA analyses. Affect scores were calculated from the 
Positive Affect (PA) and Negative Affect (NA) subscales. bComputed across the three measures.  x group differences 
exist between the indicated group and the other two groups. y group differences exist between the two indicated 
groups.  
* p < .05 

















group effects in ST, F(2, 126) = 0.031, p = .969, or LT, F(2, 126) = 0.251, p = .778, recall ratios for the spatial 
memory test. 
 
Hypothesis 2.  A significant multivariate group effect was found for the ratio of positive to negative item recall on 
the Spatial Memory test, F(4, 252) = 2.628, p = .035.  A follow-up ANCOVA revealed a significant univariate 
group effect for positive to negative item STM recall, F(2, 126) = 5.39, p = .006.  Pairwise comparisons indicated 
that OC users had a higher ratio, reflecting relatively higher recall of positive than negative items compared to both 
nonusers (p = .021) and men (p = .022).  No significant difference in the ratio of positive to negative item recall was 
found for LTM, F(2, 126) = 1.276, p = .283.  However, the direction of the means suggested that the pattern of LT 
recall was in the same direction with OC users having the largest ratio of positive to negative item recall compared 
to nonusers and men (see Figure 1 for an illustration of both ST and LT positive to negative item ratios).   
To examine whether group differences in ST recall of either positive or negative stimuli were driving the 
above findings, two ANCOVAs were conducted on these scores. ST recall of negative items significantly differed 
between groups, F(2,128) = 3.824, p = .024, with OC users recalling fewer negative items than nonusers (p = .020).  
Although ST recall of positive items did not differ significantly between groups, 
F(2,128) = 1.748, p = .178, the pattern of the means was consistent with the negative item ratio effect (see Figure 2).  
Non-parametric tests corroborated the above significant findings.  A Kruskal-Wallis analysis of ranks 
evaluating differences among the three groups in the ratio of positive to negative STM item recall was significant, X2 
(2, N = 135) = 8.58, p = .014.  Pairwise comparisons using the Mann-Whitney U test were consistent with the above 
findings of higher positive to negative item recall in OC users compared to nonusers (p = .041) and men (p = .006).  
A Kruskal-Wallis analysis of ranks evaluating differences among the three groups (OC users, nonusers, and men) on 




OC use and mood/affect.  Scores on the PANAS (i.e., means and range scores for PA and NA) were examined to see 
if group differences in affect level or variability existed over the three measures of affect across the two laboratory  






Figure 1  
Group Differences Between Nonusers, Oral Contraceptive (OC) users, and Men in the Ratio of Positive to Negative 
Items Recalled on the Emotional Spatial Memory Test. Higher ratios reflect relatively better recall of positive versus 
negative stimuli. (a) OC users had significantly larger positive to negative item ratios than nonusers (p = .021) and 
men (p = .022) for ST item recall, F(2, 126) = 5.39, p = .006. (b). No group differences were found in positive to 













ST Recall of Negatively- and Positively-Valenced Stimuli on the Emotional Spatial Memory Test as a function of 
Group (Non users, Oral contraceptive (OC) users, Men). (a) There was a group difference in recall of negative 
items, F(2,128) = 3.824, p = .024. OC users recalled significantly fewer negative items than nonusers. (b) No group 













sessions (see bottom panel of Table 4 for means and SDs).  MANCOVAs were conducted and the same covariates 
from the main analyses were used. 
There were no significant group differences in mean PA level, F(2,117) = 1.829, p = .165, or range, 
F(2,128) = 0.896, p = .411.  Thus, no further analyses were done on PA scores.   
Mean NA level differed between groups, F(2,121) = 5.201, p = .007, with nonusers having higher NA than 
OC users (p = .014) and men (p = .002). There was also a group difference in NA variability, F(2,128) = 3.457, p = 
.034.  Nonusers had a larger range in NA than men (p = .029), but did not differ from OC users (p = .393).  There 
were no group differences in NA level, F(2,121) = 1.237, p = .294, at the beginning of laboratory session I, but the 
groups differed in NA level at the end of that session, F(2,121) = 4.363, p = .015.  Nonusers had significantly higher 
negative affect than both OC users (p = .039) and men (p = .024), suggesting that viewing the emotional stimuli was 
associated with subsequently greater NA in nonusers.  In laboratory session II, NA level also differed between 
groups, F(2,121) = 5.890, p = .004. Nonusers had higher NA than men (p = .003) and showed a nonsignificant trend 
toward higher NA than OC users (p = .099).   
 
Re-examination of hypothesis 2 using negative affect as a covariate.  Given that OC use could affect emotional 
responses to the stimuli (e.g., a blunting in the NA response) which could affect relative recall of positive or 
negative stimuli, the significant analyses from hypothesis 2 were re-run with NA level at the end of laboratory 
session I included as an additional covariate.  Statistically adjusting for NA did not change the results.  The 
significant univariate group effect held for ST recall of positive to negative stimuli, F(2, 121) = 4.776, p = .010.  OC 
users (M = 0.97, SD = 0.36) significantly differed from men (M = 0.76, SD = 0.36; p = .021) but the difference with 
nonusers reduced to a strong trend (M = 0.79, SD = 0.37; p = .060).  The group difference in ST recall of negative 
items remained significant, F(2,123) = 3.382, p = .037.  OC users (M = 5.16, SD = 1.65) recalled significantly fewer 
negative items than nonusers (M = 6.10, SD = 1.71; p = .011).  Thus, this group difference was even stronger after 








The present study did not find any evidence that OC users, nonusers, and men differ on recall of emotional 
versus neutral spatial location information. However, for ST recall of positive and negative stimuli, OC users had a 
higher positive to negative item recall ratio than nonusers and men, and OC users recalled fewer negative items than 
nonusers.  Emotional group differences (i.e., higher negative affect in nonusers after viewing emotional stimuli) 
could not account for the findings.   
No evidence that OCs influence emotional versus neutral spatial memory 
There was no evidence to suggest that OCs influence memory for emotional versus neutral spatial stimuli. 
This is the first study to examine if OC use is associated with altered relative recall of emotional and neutral spatial 
information. Postma et al. (1999) found that OC use did not yield any main or interaction effects in their study on 
spatial memory but did find that there was a spatial memory advantage in the nonmenstrual compared with the 
menstrual phase in both the OC user and nonuser groups. While two other studies have suggested links between OC 
use and visuospatial ability (e.g., mental rotation) (Egan & Gleason, 2012; McCormick & Teillon, 2001), neither of 
these studies looked at visuospatial memory or spatial memory for emotional versus neutral stimuli.   
Evidence of an OC-related emotional memory valence effect 
OC users recalled relatively more positive than negative items, and significantly fewer negative items than 
nonusers, immediately after viewing the visual stimuli in the Emotional Spatial Memory test.  No effect was found 
for LT recall. This appears to be the first study to examine whether OC use is associated with differential relative ST 
recall of information with positive versus negative emotional valence. These findings suggest that OC use may 
decrease immediate recall of items with a negative valence.  While nonusers experienced higher negative affect 
levels than OC users and men after viewing the emotional stimuli, group differences in negative affect could not 
explain the group differences in memory.   
Two other studies examined the effects of OCs on LT recall of emotional stimuli.  Nielsen, Segal, and 
colleagues (2013) examined LT recall of positive, negative and neutral stimuli and did not find a simple effect of 
OC use. This is consistent with the current findings for LT recall. However, a recent study found that OC users 
subjected to a psychosocial stress test prior to the LT recall of emotional word pairs recalled fewer negative words 
compared to positive or neutral words (Mordecai et al., 2017). Also, performance was unrelated to cortisol. Overall, 
the research suggests that the effect of OCs on recall of negative stimuli may: (a) apply to both ST and LT recall of 




negative stimuli, (b) apply to both verbal and nonverbal stimuli, (c) be more prominent in stressful situations, and 
(d) be unrelated to cortisol.    
While comparisons between samples can be difficult, the tendency for OC users to recall relatively less 
negative, and more positive, information may be similar to the positive memory bias found in older individuals by 
Charles, Mather, and Carstensen (2003). While one can only speculate about mechanisms, it is worth noting that 
both OC users and older individuals (aged 65 to 80) have lower endogenous gonadal steroid hormone levels than the 
groups they were compared to in these studies (i.e., nonusers and younger individuals aged 18 to 29).   
 Given that this was not a randomized placebo design, we can only speculate about possible reasons why 
nonusers recalled significantly more negative items than OC users.  First, higher endogenous hormone levels in free 
cyclers (Gaspard et al., 1983) may selectively enhance memory for negative stimuli or OCs may dampen both 
endogenous hormone levels and memory for negative stimuli.  Such effects could be modulated through effects of 
estradiol on the prefrontal cortex, hippocampus, and amygdala as these are areas dense with estradiol receptors 
(Montague et al., 2008; Spencer et al., 2008). While previous research on memory and OCs has not typically 
considered the emotional valence of stimuli, the finding that nonusers had better recall of negative stimuli in the 
Emotional Spatial Memory test fits with other findings of better visual, visuospatial memory, or visuospatial 
working memory with higher estrogen levels (e.g. Hampson & Morley, 2013, Phillips & Sherwin, 1992; Solis-Ortiz 
& Corsi-Cabrera, 2008). While an estrogen enhancement effect for visuospatial memory could explain why 
nonusers have better recall, it is not clear why estrogen would selectively enhance recall of negative versus positive 
stimuli. One possibility is that there is greater adaptive value for periods of high estradiol to be associated with recall 
of negative stimuli versus positive stimuli (e.g., to help avoid noxious stimuli such as poisonous foods, aggressive 
men, or dangerous situations to maximize survival at ovulation or during pregnancy).  While this possibility is 
inconsistent with the findings of Gasbarri et al. (2008), a recent study suggests that high estradiol in pregnancy may 
enhance spatial working memory once mood is controlled (Hampson et al., 2015).   
The lower more stable progesterone levels in OC users compared to nonusers across the menstrual cycle 
(Coenen et al., 1996; Fleischman et al., 2010; Paoletti et al., 2004) is a second potential explanation for the higher 
recall of negatively valenced items in nonusers.  Higher progesterone has been associated with enhanced activity in 
the amygdala when viewing negative stimuli (Andreano & Cahill, 2010; van Wingen et al., 2008), higher heart rate 
while viewing negative stimuli (Ossewaarde et al., 2010), and a higher frequency of spontaneous intrusive 




recollections (SIRs) after viewing negative stimuli (Ferree, Kamat, & Cahill, 2011).  Thus, the possibility that 
lowered progesterone levels in OC users decreases memory for emotionally arousing stimuli, particularly negative 
stimuli, deserves further study.   
Third, the lower cortisol levels or blunted cortisol response to stressors (or negatively-valenced stimuli) in 
OC users versus nonusers (e.g. Bonen et al. 1991; Kirschbaum et al., 1995; 1996; Rohleder et al., 2003) might also 
account for the lower recall of negative stimuli in OC users. Recent studies have suggested links between OC use, 
cortisol response, and effects of postlearning stress in emotional memory (Merz et al., 2012; Nielsen, Segal, et al., 
2013; Nielsen et al., 2014).  One of these studies suggests that lower LT recall of negative stimuli and higher LT 
recall of positive stimuli is more likely to occur in OC users when such women are cortisol responders (Nielsen, 
Segal, et al., 2013). It is not clear if this would also apply to immediate recall. However, as noted above, one study 
found lower recall of negative words following stress in OC users was unrelated to cortisol (Mordecai et al., 2017).  
Two final possible mechanisms involve the amygdala. First, decreased amygdala activity might play a role 
in the OC-related memory deficit for negative stimuli. This possibility is raised by evidence that OC users show 
decreased bilateral amygdala reactivity in response to negatively valenced emotional stimuli compared to nonusers 
(Peterson & Cahill, 2015). 
Finally, a sex-related neurobiological explanation for lower recall of negative stimuli in OC users may 
relate to the finding that OC users show reduced gray matter in the left amygdala/anterior parahippocampal gyrus 
(Lisofsky et al., 2016). An OC-related left amygdala gray matter reduction may be relevant given that a systematic 
review by Baas, Aleman, and Kahn (2004) found that the left amygdala is more often activated than the right 
amygdala during emotional processing. Furthermore, Killgore and Yurgelun-Todd (2001) found that both sexes 
showed greater left amygdala activation for fearful faces, while happy faces produced greater right than left 
amygdala activation for males but not females. A recent meta-analysis also examined sex differences in brain 
activation to emotional stimuli (Stevens & Hamann, 2012). The majority of sex differences where women show 
lower activity than men have been observed for positive emotion, whereas the majority of sex differences where 
women show higher activity than men are observed for negative emotion.  Given that OC users’ memory 
performance for negative stimuli was shifted towards male-like responses, and that men are more likely to show 
lower brain activity than women with negative emotions, the current finding of lower recall of negative stimuli in 
OC users may suggest an OC-related masculinization of brain structures involved in emotional memory.  




Strengths and Limitations  
The survivor effect (e.g., Kutner & Brown, 1972) is a potential limitation in any study on OC use without 
random assignment to groups.  Thus, the study is limited in fully demonstrating the effect of OCs on emotional 
memory because the OC users were ‘surviving’ self-selected users.  The findings may therefore suggest that women 
who choose to continue OC use (possibly due to fewer negative side effects, no side effects, or positive side effects) 
recall fewer negative stimuli than nonusers. 
In terms of strengths, this is the first study to examine whether OCs affect relative recall of emotional 
versus neutral spatial information. Second, this is the first study to examine whether OCs affect memory for 
positively- and negatively-valenced stimuli independent of a stress-induction paradigm. Fourth, we included a 
number of methods to measure and control for group difference in other variables that could affect mood or 
memory.  Additional strengths include sample size, controls for menstrual cycle phase, and the inclusion of men.   
Conclusions and Future Directions  
Our findings suggest that OC users and nonusers who experience the same emotional stimuli, or an 
emotional event in the real world, may process and remember that information in different ways.  This could have 
implications for sex differences in symptoms of depression, anxiety, or post-traumatic stress. The lower retention of 
aversive or negative stimuli in OC users may suggest that OC use could lessen the risk or severity of these types of 
symptoms for some women.  Future studies should focus on replicating the current finding of reduced memory for 
negative stimuli in OC users, and examine possible mechanisms for such an effect.  If replicable, it will be important 
to determine whether the effect is due to an effect of OCs on encoding, consolidation, retrieval, or all three.  Future 
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